help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 15, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1645
A more recent version of this article appeared on November 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/11/4205    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by New, M. I
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by New, M. I

Submitted on July 28, 2006
Accepted on August 4, 2006

Extensive Personal Experience: Nonclassical 21-Hydroxylase Deficiency

Maria I New MD*

Mount Sinai School of Medicine, Department of Pediatrics, New York, NY

* To whom correspondence should be addressed. E-mail: maria.new{at}mssm.edu.

Context: Nonclassical congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (NC21OHD) is the most frequent of all autosomal recessive genetic diseases occurring in 1 in 100 in persons the heterogeneous New York City population. NC21OHD occurs with increased frequency in certain ethnic groups, such as Ashkenazi Jews, in who 1 in 27 express the disease. NC21OHD is underdiagnosed in both male and female patients with hyperandrogenic symptoms because hormonal abnormalities in NC21OHD are only mild to moderate, not severe as in the classical disease. Unlike classical congenital adrenal hyperplasia, NC21OHD is not associated with ambiguous genitalia in the female.

Main outcome measures: The hyperandrogenic symptoms include advanced bone age, early pubic hair, precocious puberty, tall stature and early arrest of growth in children; infertility, severe cystic acne, and short stature in both adult males and females; hirsutism, frontal balding, polycystic ovaries and irregular menstrual periods in females; and testicular adrenal rest tissue in males.

Conclusions: The signs and symptoms of hyperandrogenism are reversed with dexamethasone treatment.


Key words: congenital adrenal hyperplasia • 21-hydroxylase deficiency • nonclassical 21-hydroxylase deficiency




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
K. LIN-SU, S. NIMKARN, and M. I. NEW
Congenital Adrenal Hyperplasia in Adolescents: Diagnosis and Management
Ann. N.Y. Acad. Sci., June 1, 2008; 1135(1): 95 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. S. Araujo, B. B. Mendonca, A. S. Barbosa, C. J. Lin, J. A. M. Marcondes, A. E. C. Billerbeck, and T. A. S. S. Bachega
Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 4028 - 4034.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society